Cohance Lifesciences
COHANCENSE

Cohance Lifesciences

₹423.80-14.30 (3.26%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
423.10
Today’s high
439.80
52 week low
266.70
52 week high
1,079.00
Open price
439.80
Previous close
438.10
Live volume
5,11,275
Lower circuit
350.50
Upper circuit
525.70

Fundamentals

Market Cap
₹16,793Cr
ROE
5.05%
P/E Ratio(TTM)
111.98
EPS(TTM)
3.92
P/B Ratio
4.29
Dividend Yield
0.00%
Industry P/E
36.67
Book Value
102.24
Debt to Equity
0.10
Face Value
1

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
₹617
+12.09%
Profit (Cr)
₹8.31
-71.36%
02505007501k
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)-28%
3Y CAGR-4%
Profit growthValue
1Y (TTM)-93%
3Y CAGR-16%

About

Cohance Lifesciences Limited is a contract development and manufacturing organization (CDMO) and API manufacturer.;
CEO/MD
Dr V. Prasada Raju
Founded in
2020
NSE symbol
COHANCE

Shareholding Pattern

Jun '26
Mar '26
Dec '25
Sep '25
Jun '25
Promoters
66.41%
Retail And Others
14.96%
Mutual Funds
8.90%
Foreign Institutions
7.23%
Other Domestic Institutions
2.50%

Mutual Funds Invested (4)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹1,239.70
-10.80 (0.86%)
L
    H
    26,541.1176.0510.69
    ₹18,443.00
    -23.00 (0.12%)
    L
      H
      23,732.6065.212.67
      ₹181.90
      +4.80 (2.71%)
      L
        H
        23,571.52--2.89
        ₹1,660.50
        -11.00 (0.66%)
        L
          H
          19,189.41--3.29
          2026
          12
          May
          Quarterly & Annual Result
          Release date
          12
          Feb
          Quarterly Result
          Release date
          2025
          12
          Nov
          Quarterly Result
          Release date
          13
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks